Inflammation and Oxidative Stress in Chronic Kidney Disease-Potential Therapeutic Role of Minerals, Vitamins and Plant-Derived Metabolites.
Shara Francesca RapaBiagio Raffaele Di IorioPietro CampigliaAugust HeidlandStefania MarzoccoPublished in: International journal of molecular sciences (2019)
Chronic kidney disease (CKD) is a debilitating pathology with various causal factors, culminating in end stage renal disease (ESRD) requiring dialysis or kidney transplantation. The progression of CKD is closely associated with systemic inflammation and oxidative stress, which are responsible for the manifestation of numerous complications such as malnutrition, atherosclerosis, coronary artery calcification, heart failure, anemia and mineral and bone disorders, as well as enhanced cardiovascular mortality. In addition to conventional therapy with anti-inflammatory and antioxidative agents, growing evidence has indicated that certain minerals, vitamins and plant-derived metabolites exhibit beneficial effects in these disturbances. In the current work, we review the anti-inflammatory and antioxidant properties of various agents which could be of potential benefit in CKD/ESRD. However, the related studies were limited due to small sample sizes and short-term follow-up in many trials. Therefore, studies of several anti-inflammatory and antioxidant agents with long-term follow-ups are necessary.
Keyphrases
- chronic kidney disease
- end stage renal disease
- anti inflammatory
- oxidative stress
- kidney transplantation
- coronary artery
- heart failure
- ms ms
- dna damage
- diabetic rats
- ischemia reperfusion injury
- cardiovascular disease
- induced apoptosis
- pulmonary artery
- risk factors
- case control
- type diabetes
- cardiovascular events
- bone mineral density
- stem cells
- soft tissue
- peritoneal dialysis
- bone marrow
- risk assessment
- signaling pathway
- mesenchymal stem cells
- cell wall
- bone regeneration